Exclusive

Publication

Byline

Clinical Trial: Comparison of Pre-Shock Pause Times Among Defibrillator Models During Cardiopulmonary Resuscitation (Japan)

Tokyo, Sept. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062856) titled 'Comparison of Pre-Shock Pause Times Among Defibrillator Models During Card... Read More


Clinical Trial: A Prospective Observational Study of Changes in Hospital Notification Skills Following Repeated Use of a Web-Based Learning Support Application for Emergency Medical Technicians (Japan)

Tokyo, Sept. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062854) titled 'A Prospective Observational Study of Changes in Hospital Notification Skil... Read More


Clinical Trial: Exploratory study on multifaceted health values of test food (Japan)

Tokyo, Sept. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062853) titled 'Exploratory study on multifaceted health values of test food' on Sept. 9. ... Read More


Clinical Trial: Registry for Automated Mechanical VEntilation in Adults in Japan (Japan)

Tokyo, Sept. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062852) titled 'Registry for Automated Mechanical VEntilation in Adults in Japan' on Sept.... Read More


Alebund receives FDA clearance to advance first-in-class AP308 into IgA nephropathy trial

Singapore, Sept. 9 -- Alebund Pharmaceuticals has received clearance from the US Food and Drug Administration for the Investigational New Drug application of AP308, a first-in-class engineered recombi... Read More


Kelun-Biotech partner advances ultra-long-acting asthma antibody into Phase III

Singapore, Sept. 9 -- Kelun-Biotech has reported positive interim Phase II results for SKB378/WIN378, an investigational ultra-long-acting monoclonal antibody targeting thymic stromal lymphopoietin, a... Read More


Accro and Fosun advance oral TYK2/JAK1 inhibitor AC-201 into China Phase II/III vitiligo trial

Singapore, Sept. 9 -- Accro Bioscience and Fosun Pharma are preparing to advance AC-201 into a Phase II/III clinical trial in China for non-segmental vitiligo following regulatory clearance from the N... Read More


OFM pushes up PinkTober!

South Africa, Sept. 9 -- Under the theme Pushing Up PinkTober, OFM is dedicating its time, energy, and airwaves throughout October to raising funds for Cansa and Reach for Recovery, with every contrib... Read More


Generated doesn't mean designed. How designers are working with AI.

South Africa, Sept. 9 -- I've stopped being surprised when a new AI tool makes last month's setup feel outdated. What still catches me off guard is how many designers are chasing the tool itself, as i... Read More


France takes centre stage at Fame Week Africa 2026

South Africa, Sept. 9 -- This October, France takes centre stage at Fame Week Africa as the 2026 Destination Focus, bringing French and African creatives, producers, buyers, distributors, entrepreneur... Read More